BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination..
- BeyondSpring Dosed First Patient of Two Phase 2 Investigator-Initiated Trials (IIT) in Plinabulin and Keytruda Combination..
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the Phase 3..
Submitted FDA De Novo application for ARC-EX^® SystemSuccessfully raised EUR 20M in equity capital
Announced positive..